- Home
- FHTX vs JAKK Comparison
FHTX vs JAKK Comparison
Compare FHTX & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- JAKK
- Stock Information
- Founded
- FHTX 2015
- JAKK 1995
- Country
- FHTX United States
- JAKK United States
- Employees
- FHTX N/A
- JAKK N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- JAKK Recreational Games/Products/Toys
- Sector
- FHTX Health Care
- JAKK Consumer Discretionary
- Exchange
- FHTX Nasdaq
- JAKK Nasdaq
- Market Cap
- FHTX 278.1M
- JAKK 231.8M
- IPO Year
- FHTX 2020
- JAKK 1996
- Fundamental
- Price
- FHTX $4.89
- JAKK $16.63
- Analyst Decision
- FHTX Strong Buy
- JAKK Strong Buy
- Analyst Count
- FHTX 8
- JAKK 4
- Target Price
- FHTX $12.63
- JAKK $41.75
- AVG Volume (30 Days)
- FHTX 118.7K
- JAKK 178.7K
- Earning Date
- FHTX 08-05-2025
- JAKK 07-24-2025
- Dividend Yield
- FHTX N/A
- JAKK 5.88%
- EPS Growth
- FHTX N/A
- JAKK 25.15
- EPS
- FHTX N/A
- JAKK 3.34
- Revenue
- FHTX $24,173,000.00
- JAKK $684,694,000.00
- Revenue This Year
- FHTX $33.60
- JAKK N/A
- Revenue Next Year
- FHTX $5.87
- JAKK $4.01
- P/E Ratio
- FHTX N/A
- JAKK $5.09
- Revenue Growth
- FHTX N/A
- JAKK 1.31
- 52 Week Low
- FHTX $2.95
- JAKK $16.87
- 52 Week High
- FHTX $10.25
- JAKK $35.79
- Technical
- Relative Strength Index (RSI)
- FHTX 42.08
- JAKK 30.65
- Support Level
- FHTX $4.72
- JAKK $17.05
- Resistance Level
- FHTX $5.24
- JAKK $17.63
- Average True Range (ATR)
- FHTX 0.41
- JAKK 0.70
- MACD
- FHTX -0.16
- JAKK -0.12
- Stochastic Oscillator
- FHTX 13.73
- JAKK 3.30
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.